Floatz logo

CYPROTERONE

Metastatic Castration-sensitive Prostate Cancer

BayerSmall moleculeActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Metastatic Castration-sensitive Prostate Cancer cohort.

Asset / SponsorPhaseRating
Histrelin
Bayer
Phase 2/3B
Abiraterone Acetate
Astellas Pharma Global Development, Inc.
Phase 1CC
BUSERELIN
Bayer
D

Same molecule, other indications

CYPROTERONE is also rated in:

polycystic ovary syndromeDormant
BBB
Indicative ·
72 / 100
View asset →
Menstrual IrregularitiesDormant
BB
Indicative ·
65 / 100
View asset →
prostate cancerDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →